Cite
HARVARD Citation
Nomoto, H. et al. (2022). Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study). BMJ open diabetes research and care. 10 (6), p. . [Online].